Sexual HealthEarly research

Bremelanotide Nasal

PT-141 Intranasal Formulation

AI explanation

Bremelanotide Nasal

Bremelanotide nasal is a peptide spray you inhale through your nose that's designed to help people who struggle with sexual desire or arousal. It's a needle-free alternative to the injected version that's already FDA-approved, and it works by tapping into your brain's natural arousal systems rather than doing anything mechanical in your body.

Here's how it actually functions: when you spray it into your nasal passages, the peptide gets absorbed through the delicate tissue lining your nose and enters your bloodstream. From there, it travels to specific receptors in your hypothalamus—think of this as your brain's control center for desire and arousal. The peptide essentially flips switches on these receptors, which triggers your brain to release dopamine, the same chemical involved in pleasure and motivation. This naturally revs up your sexual interest and physical response within about twenty to thirty minutes.

The intranasal route is appealing because you skip the needle, though it does deliver slightly lower peak levels compared to injection. The tradeoff is that some people experienced temporary blood pressure increases in earlier studies, which is partly why researchers ultimately preferred the injected form for the official FDA approval. But the nasal version remains useful for people who want to avoid needles while accessing the same core mechanism.

Dosage Information

Typical Dose

1-2 mg intranasal

Frequency

As needed, at least 45 minutes before sexual activity

Anytime

Administration

Intranasal spray

Half-Life

2–3 hours

Notes

Not FDA-approved — compounded intranasal formulations exist outside the approved injectable product. Onset typically 20-30 minutes. Blood pressure monitoring recommended as with injectable form.

Why this matters

Nasal form of PT-141; FDA-approved as Vyleesi with effects lasting hours.

Protocol cycle

as needed· Use 45 minutes before sexual activity

Where does Bremelanotide Nasal sit?

See how this peptide compares across all 150 peptides in our database.

Evidence Score

0.07

Clinical trials
0.0035%
Literature
0.0030%
Community
0.0020%
Completeness
0.5015%

Potential Side Effects

Nausea (common)Flushing (common)Nasal irritation (common with intranasal route)Blood pressure changes (uncommon — monitor)Headache (uncommon)
Pep Talk

Bremelanotide Nasal discussions

Quick Facts

Administration
Intranasal spray
Typical Dose
1-2 mg intranasal
Frequency
As needed, at least 45 minutes before sexual activity
References
0 curated + 0 from PubMed
Evidence Score
0.1 / 100

Frequently Asked Questions about Bremelanotide Nasal

What is Bremelanotide Nasal?

Bremelanotide intranasal is the nasal spray formulation of PT-141 (bremelanotide) that was studied in early clinical trials before the injectable autoinjector formulation was approved by the FDA. The intranasal route was originally used in Phase 1 and 2 trials and showed efficacy for sexual dysfunction in both men and women. While the approved Vyleesi formulation is subcutaneous injection the intranasal formulation continues to be used in research and compounded formulations where it offers a needle-free alternative with slightly different pharmacokinetics.

How does Bremelanotide Nasal work?

Bremelanotide nasal acts through the same melanocortin receptor mechanism as the injectable form — MC3R and MC4R agonism in the hypothalamus driving dopamine release and sexual arousal circuits. The intranasal route delivers the peptide across the nasal mucosa with absorption into the systemic circulation and potentially some direct CNS delivery via olfactory and trigeminal nerve pathways. The onset of action is typically 20-30 minutes with slightly lower peak plasma levels compared to subcutaneous injection but a similar duration of effect. The intranasal formulation was found to have higher rates of transient blood pressure elevation in early trials leading to the preference for the subcutaneous formulation in the approved product.

What is the recommended dosage for Bremelanotide Nasal?

The typical dose is 1-2 mg intranasal. As needed, at least 45 minutes before sexual activity. Administration: Intranasal spray. Not FDA-approved — compounded intranasal formulations exist outside the approved injectable product. Onset typically 20-30 minutes. Blood pressure monitoring recommended as with injectable form.

What are the side effects of Bremelanotide Nasal?

Nausea (common). Flushing (common). Nasal irritation (common with intranasal route). Blood pressure changes (uncommon — monitor). Headache (uncommon)

What is the Bremelanotide Nasal cycle protocol?

Bremelanotide Nasal is typically cycled as needed. Use 45 minutes before sexual activity

Questions reflect common community inquiries. This is not medical advice.